BIO-key International, Inc.
BKYI
$0.78
$0.0314.14%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -5.15% | -3.86% | 6.74% | 10.47% | 24.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.15% | -3.86% | 6.74% | 10.47% | 24.07% |
| Cost of Revenue | -45.29% | -8.03% | 54.94% | 159.21% | 194.83% |
| Gross Profit | 88.84% | 2.23% | -36.22% | -68.75% | -47.35% |
| SG&A Expenses | -17.16% | -21.73% | -18.48% | -15.73% | 10.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -24.50% | -18.00% | -4.54% | 10.13% | 28.77% |
| Operating Income | 40.65% | 28.67% | 13.85% | -9.83% | -32.99% |
| Income Before Tax | 56.57% | 50.19% | 40.74% | 27.45% | -79.24% |
| Income Tax Expenses | -326.14% | -325.94% | -556.86% | -556.86% | -- |
| Earnings from Continuing Operations | 59.12% | 52.69% | 41.71% | 28.45% | -80.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 59.12% | 52.69% | 41.71% | 28.45% | -80.95% |
| EBIT | 40.65% | 28.67% | 13.85% | -9.83% | -32.99% |
| EBITDA | 0.82% | -10.93% | -29.86% | -58.51% | -33.98% |
| EPS Basic | 77.39% | 69.08% | 54.59% | 40.30% | -63.37% |
| Normalized Basic EPS | 91.87% | 78.74% | 62.43% | 42.43% | -35.32% |
| EPS Diluted | 77.39% | 69.08% | 54.59% | 40.30% | -63.37% |
| Normalized Diluted EPS | 91.87% | 78.74% | 62.43% | 42.43% | -35.32% |
| Average Basic Shares Outstanding | 177.32% | 126.41% | 79.46% | 20.62% | 16.44% |
| Average Diluted Shares Outstanding | 177.32% | 126.41% | 79.46% | 20.62% | 16.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |